PlainPharmaWatch

CMS Open Payments · Tool

Surgical Theater. Inc. vs Ascensia Diabetes Care Us Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Surgical Theater. Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 3,868, versus 181 for the other company. Its single largest recorded recipient represents 0.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Surgical Theater. Inc.
HHI 3,868 · top recipient 0.6%
Ranked #458 of 1,838 companies by HHI
Ascensia Diabetes Care Us Inc.
HHI 181 · top recipient 0.1%
Ranked #1,578 of 1,838 companies by HHI

Payment Overview

Total Payments
$257.7K
% of Industry
0.0%
Transactions
135
Avg per Transaction
$1.9K
Recipients
131
Avg per Recipient
$2.0K
Payment Types
6
Top Payment Type
Consulting Fee
Total Payments
$258.2K
% of Industry
0.0%
Transactions
3,812
Avg per Transaction
$67.73
Recipients
3,812
Avg per Recipient
$67.73
Payment Types
5
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Surgical Theater. Inc. vs Ascensia Diabetes Care Us Inc. - total reported payments in CMS Open Payments PY2024

Ascensia Diabetes Care Us I…$258.2KSurgical Theater. Inc.$257.7K

Payment Types Breakdown

Surgical Theater. Inc.

Consulting Fee $113.2K

43.9%

Gift $54.0K

21.0%

Travel and Lodging $16.3K

6.3%

Food and Beverage $11.4K

4.4%

Compensation for Services Other Than Consulting $4.0K

1.6%

Royalty or License $1.1K

0.4%

Ascensia Diabetes Care Us Inc.

Consulting Fee $93.6K

36.3%

Food and Beverage $89.7K

34.7%

Compensation for Services Other Than Consulting $64.8K

25.1%

Travel and Lodging $9.9K

3.8%

Entertainment $155.55

0.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Surgical Theater. Inc.

  1. 1

    Robert Louis Mr

    $115,937.29 · 16 txns

  2. 2

    Cedars-Sinai Medical Center

    $42,000.00 · 1 txns

  3. 3

    Thomas Jefferson Univ. Hospital

    $12,000.00 · 1 txns

  4. 4

    Walter Jean Mr

    $7,891.56 · 11 txns

  5. 5

    Gregory Poulter Mr

    $5,198.71 · 13 txns

Ascensia Diabetes Care Us Inc.

  1. 1

    MARK CORRIERE

    $14,827.54 · 9 txns

  2. 2

    GARY GRAF

    $13,643.51 · 24 txns

  3. 3

    DAVID AHN

    $13,133.01 · 23 txns

  4. 4

    AMIR HARARI

    $10,528.05 · 10 txns

  5. 5

    KELSEY FURR

    $9,279.38 · 35 txns

Summary Comparison

Metric Surgical Theater. Inc. Ascensia Diabetes Care Us Inc.
Total Payments $257.7K $258.2K
% of Industry Total 0.0% 0.0%
Transaction Count 135 3,812
Avg per Transaction $1.9K $67.73
Recipient Count 131 3,812
Avg per Recipient $2.0K $67.73
Payment Type Count 6 5
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.